Tirzepatide 30 MG – Dual-Agonist Peptide for Metabolic & metabolic studies Research

Product Description

Tirzepatide – Dual GLP-1 and GIP Receptor Agonist for Metabolic Regulation and Weight Research

Composition: 30 mg Tirzepatide (lyophilized peptide powder)
Category: Peptide
Form: Vial with freeze-dried powder
Administration: Subcutaneous research application (requires reconstitution)

What is Tirzepatide?

Tirzepatide is a next-generation incretin peptide that acts as a dual receptor agonist, simultaneously binding to the GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.
This dual mechanism provides synergistic effects on glucose metabolism, satiety signaling, and body composition—making Tirzepatide a key research compound in the field of metabolic and obesity studies.

By targeting both pathways, Tirzepatide investigated for influence on insulin secretion, investigated for effects on glucose utilization, associated with satiety, and supports long-term adipose tissue studies.
It has demonstrated significant potential in preclinical and clinical investigations focused on metabolic optimization and endocrine regulation.

➡️ Ideal for studies on insulin pathway research, body composition, and energy metabolism.

Key Research Findings

• Dual Receptor Activation: Engages both GLP-1 and GIP receptors for amplified incretin signaling and superior metabolic outcomes.
• Glucose Regulation: investigated for influence on glucose-dependent insulin secretion and supports influenced glycemic pathway studies.
• adipose tissue studies: Demonstrated in studies to significantly studied for modulation of adipose mass while maintaining lean tissue.
• satiety signaling: Modulates hypothalamic centers to modulate satiety signals and extend satiety periods.
• Energy Metabolism: investigated for effects on mitochondrial efficiency and associated with lipid oxidation for supported energy expenditure.

Mechanism of Action

Tirzepatide acts through dual activation of GLP-1 and GIP receptors, two incretin pathways crucial to metabolic regulation.
GLP-1 receptor activation investigated for influence on insulin release and investigated for modulation of appetite, while GIP receptor engagement complements this by influencing insulin pathway research and lipid metabolism.
The combined effect results in influenced glycemic pathway studies, modulated body fat, and optimized energy balance.

Dosage and Application

Reconstitute with bacteriostatic water before use.

Commonly referenced research protocols: 0.25 – 1.0 mg per application, used in subcutaneous research models once or twice weekly depending on study design.

Store the reconstituted solution in a refrigerator and use within 30 days.

Storage Instructions

• Store at 2–8 °C (36–46 °F)
• Protect from light and moisture
• Do not freeze
• Avoid temperature fluctuations

Why Choose Tirzepatide?

Tirzepatide represents one of the most advanced peptides in incretin-based research, offering dual metabolic modulation through GLP-1 and GIP receptor activation.
Its comprehensive effects on glucose metabolism studies, satiety pathway modulation, and lipid metabolism make it an essential compound for metabolic and obesity research.
With its extended duration of action and balanced endocrine profile, Tirzepatide enables long-term study designs in metabolic regulation studies and energy management.

Explore the potential of Tirzepatide 30 mg for advanced research in metabolic optimization, insulin pathway research, and body composition studies.

Technical Specifications

• Product Code: TIRZEPATIDE-10MG
• Purity: ≥98% (HPLC)
• Form: Lyophilized powder
• Storage: –20 °C (before reconstitution), 2–8 °C (after reconstitution)
• Stability: 2 years lyophilized, 30 days reconstituted when properly stored

Quality Assurance

Every batch undergoes strict analytical testing to ensure accuracy and consistency:

• HPLC analysis for purity confirmation
• Mass spectrometry for molecular identity verification
• Endotoxin and sterility testing for research-grade validation

References and Further Reading

For more information, consult peer-reviewed literature available on PubMed covering Tirzepatide’s dual receptor activation and its implications in metabolic, endocrine, and obesity research.
All products are manufactured in accordance with modern research standards and laboratory best practices.